相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ultrahypofractionation Should be a Standard of Care Option for Intermediate-Risk Prostate Cancer
A. Loblaw
CLINICAL ONCOLOGY (2020)
Target motion mitigation promotes high -precision treatment planning and delivery of extreme hypofractionated prostate cancer radiotherapy: Results from a phase II study
Carlo Greco et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO and AUA Evidence-Based Guideline
Scott C. Morgan et al.
JOURNAL OF UROLOGY (2019)
Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy A Phase 3 Randomized Clinical Trial
Deborah W. Bruner et al.
JAMA ONCOLOGY (2019)
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
Anders Widmark et al.
LANCET (2019)
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial
Douglas H. Brand et al.
LANCET ONCOLOGY (2019)
Moderate Hypofractionation in Intermediate- and High-Risk, Localized Prostate Cancer: Health-Related Quality of Life From the Randomized, Phase 3 HYPRO Trial
Ruud C. Wortel et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Patient- versus physician-reported outcomes in prostate cancer patients receiving hypofractionated radiotherapy within a randomized controlled trial
Elke Rammant et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2019)
Patient-reported Urinary, Bowel, and Sexual Function After Hypofractionated Intensity-modulated Radiation Therapy for Prostate Cancer Results From a Randomized Trial
Karen E. Hoffman et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2018)
Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer
Himanshu R. Lukka et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer
Charles N. Catton et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer
W. Robert Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial
Luca Incrocci et al.
LANCET ONCOLOGY (2016)
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
David Dearnaley et al.
LANCET ONCOLOGY (2016)
Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
J. L. Donovan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial
Shafak Aluwini et al.
LANCET ONCOLOGY (2015)
Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
Anna Wilkins et al.
LANCET ONCOLOGY (2015)
Measuring health-related quality of life in men with prostate cancer: A systematic review of the most used questionnaires and their validity
Esther H. J. Hamoen et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
Quality of life and toxicity after SBRT for organ-confined prostate cancer, a 7-year study
Alan Jay Katz et al.
FRONTIERS IN ONCOLOGY (2014)
An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancer
George van Andel et al.
EUROPEAN JOURNAL OF CANCER (2008)
Quality of life and satisfaction with outcome among prostate-cancer survivors
Martin G. Sanda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Quality of life measurement: bibliographic study of patient assessed health outcome measures
AN Garratt et al.
BMJ-BRITISH MEDICAL JOURNAL (2002)
分享论文
